Yuan, JiandaZhou, JunDong, ZhiwanTandon, SapnaKuk, DeborahPanageas, Katherine SWong, PhilipWolchok, Jedd DHodi, F Stephen2014-07-072013Yuan, Jianda, Jun Zhou, Zhiwan Dong, Sapna Tandon, Deborah Kuk, Katherine S Panageas, Philip Wong, Jedd D Wolchok, and F Stephen Hodi. 2013. “Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.” Journal for Immunotherapy of Cancer 1 (Suppl 1): P247. doi:10.1186/2051-1426-1-S1-P247. http://dx.doi.org/10.1186/2051-1426-1-S1-P247.2051-1426http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407008en-USPre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumabOther2014-07-0710.1186/2051-1426-1-S1-P247